Nusano
West Valley City, Utah, United States · Biotechnology, Health Care, Information Technology
Nusano is a medical technology company that creates radioisotopes—tiny tracers used by doctors to diagnose and treat cancer and other diseases. Doctors use these tiny tracers like flashlights to light up areas inside the body. They can see how blood is flowing, how organs are functioning, even how cells are growing. Advanced medicines and treatment methods also use radioisotopes to target and elim
Key facts
- Headquarters
- West Valley City, Utah, United States
- Employees
- 170
- Industries
- Biotechnology, Health Care, Information Technology
- Status
- Private
- Website
- www.nusano.com
- Company page
Recent activity at Nusano
- : Nusano and Ariceum Therapeutics Forge Multi-Isotope Supply Agreement to Enhance Cancer Treatment Options. (date Fundz recorded it)
- : Nusano and Cellectar Biosciences Enter Multi-Year Isotope Supply Agreement to Support Cancer Drug Development (date Fundz recorded it)
- : Nusano and Atley Solutions Collaborate to Develop Astatine-211 Solutions for Oncology Therapeutics.
- : Nusano Establishes Medical Radioisotopes Advisory Board to Enhance Cancer Therapy Development.
- : Nusano raised over $115M in Series C funding led by The Wasatch Group to support the initial product launches of non-carrier-added lutetium-177 and actinium-225.
- : Nusano Announces Series C Financing of Over $115M with The Wasatch Group and S32 (date Fundz recorded it)
- : Nusano Names Rohan Jain as Commercial General Manager
- : Nusano Appoints Industry Expert Alexandre Gibim as Chief
- : Nusano, Inc
- : Nusano, Inc.
Dates are the day the event happened, taken from the announcement or SEC filing, unless a row says otherwise.
Nusano funding history
| Date | Round | Amount |
|---|---|---|
| Oct 2024 | Series C | $115.0M |
| Nov 2022 | Venture | $10.0M |
| Sep 2021 | Venture | $48.0M |
| Oct 2018 | Venture | $41.5M |
| Nov 2017 | Seed | $800K |
Leadership
- Marisela Mims, Director of Human Resources
- Howard Lewin, Executive Officer, Director
- R. MCKERNAN, Executive Officer, Director
- MICHAEL PELLINI, Director
- ANDREW CONRAD, Director
- ANDREW HARRISON, Director
- Mike Pellini, Director
- Glenn Rosenthal, Executive Officer, Director
Verified email and direct lines for Nusano’s decision-makers are on Fundz. See plans or book a 15-minute walkthrough.
Employee benefit plans
Nusano files 1 employee benefit plan with the U.S. Department of Labor. The next plan year renews in Dec 2026.
Nusano in the news
- Nusano selected for DOE HALEU program - Nuclear Engineering International (Sep 28, 2026)
- Nusano, Primo Biotechnology ink isotope supply deal - AuntMinnie (Oct 14, 2026)
- Nusano Hosts VIP Preview Tour of New Utah Factory with Gadolinium-160 Breakthrough and Ion Beam Innovation - TechBuzz News (Jun 11, 2025)
- Nusano Opens New Radioisotope Production Facility in Utah - Imaging Technology News (Aug 26, 2025)
- Nusano cuts ribbon on state-of-the-art radioisotope production facility - Utah Business (Sep 17, 2025)
- Nusano’s HALEU platform gets a spot in a DOE nuclear fuel deployment program, putting its technology into the federal push to expand advanced reactor supply chains - Energies Media (Sep 24, 2026)
- Higher-enriched uranium for datacenters has DoE all aglow - The Register (Sep 15, 2026)
- Ratio Therapeutics and Nusano Enter Long-Term, Multi-Isotope Supply Agreement to Boost Production of Cancer Radiopharmaceuticals - PR Newswire (Jun 17, 2025)
Companies similar to Nusano
- MedShift · Biotechnology, Health Care, Information Technology, Manufacturing, Medical, Medical Device
- RADNOSTIX · Biotechnology, Health Care, Information Technology, Manufacturing, Medical, Medical Device
- QTREX Quantum Ltd · Biotechnology, Health Care, Information Technology, Manufacturing, Medical, Medical Device
- Monogram Technologies · Biotechnology, Health Care, Information Technology, Manufacturing, Medical, Medical Device
- Swiss Technology Group · Biotechnology, Health Care, Information Technology, Manufacturing, Medical, Medical Device
About Nusano: questions and answers
What does Nusano do?
Nusano is a medical technology company that creates radioisotopes—tiny tracers used by doctors to diagnose and treat cancer and other diseases. Doctors use these tiny tracers like flashlights to light up areas inside the body. They can see how blood is flowing, how organs are functioning, even how cells are growing. Advanced medicines and treatment methods also use radioisotopes to target and elim
Where is Nusano headquartered?
Nusano is headquartered in West Valley City, Utah, United States.
How many employees does Nusano have?
Nusano has about 170 employees.
Has Nusano raised funding?
Yes. Fundz has recorded 5 funding events for Nusano. The most recent, Series C of $115.0M, was in Oct 2024.
What is the latest news on Nusano?
On Oct 14, 2025, Nusano and Ariceum Therapeutics Forge Multi-Isotope Supply Agreement to Enhance Cancer Treatment Options.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy